Moderna says preparing for launch of experimental coronavirus vaccine

Moderna recently finished enrolling participants for a 30,000-volunteer study

  
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020.

A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020.

REUTERS/Brian Snyder

Moderna Inc said on Thursday it was preparing to launch its experimental coronavirus vaccine, which is currently being tested in a large human trial, and was in talks with a WHO-led group for distribution.

Moderna recently finished enrolling participants for a 30,000-volunteer study that is testing whether the vaccine can help prevent COVID-19. Early data from the trial is expected in the coming weeks.

The company said it was in talks with the World Health Organization-backed COVAX facility on a tiered pricing proposal for its vaccine.

(Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty) ((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780, outside U.S. +91 806749 2709;))

More From Health